GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO Study
While some patients may notice a decrease in appetite within a few days of starting the medication, others may take longer to feel its full effects
However, it remains under investigation whether these benefits are directly due to the GLP-1 agonists or a result of the weight loss they facilitate
this most likely results from strong allosteric effects associated with Y2-R/G interactions that place the cell in a refractory state and prevent further signaling 48
Cell 2015;160:829-41.ArticlePubMedPMC 48
La clase de medicamentos que se recomienda, conocida formalmente como agonistas de GLP-1, puede suprimir el apetito de una persona al imitar una hormona que seala al cerebro cuando una persona est satisfecha